EUVIMEDEUVIMED entdecken
Crossref

Delayed contrast MRI for the evaluation of Ménière’s disease: an Australian perspective

Emily Barrett iD, Rudolf Boeddinghaus, Andrew Thompson, Andre Wedekind, Dayse Tavora-Vieira, Jafri Kuthubutheen

The Journal of Laryngology & Otology · 2025

DOI: 10.1017/s0022215124001671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Laryngology & Otology, 2025. Verfasst von Emily Barrett und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Head and Neck Surgery, Sir Charles Gairdner Hospital, Nedlands, Australia. Hauptthemen laut MEDLINE: Meniere Disease, Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Ménière’s disease is a chronic inner-ear disease attributed to endolymphatic hydrops. Magnetic resonance imaging with gadolinium allows visualisation of endolymphatic hydrops in vivo and may be an adjunct to diagnosis.

Methods

Thirty-eight patients suspected of having Ménière’s disease underwent T2 weighted three-dimensional fluid-attenuated inversion recovery and true inversion recovery sequence magnetic resonance imaging 4 hours post double-dose intra-venous gadolinium. Presence of endolymphatic hydrops was graded by two radiologists at 0 and 4 months. Correlation to clinical diagnosis was assessed using Fisher’s exact test.

Results

Hydrops was identified in 88 per cent, 17 per cent and 27 per cent of patients with Definite Ménière’s, Probable Ménière’s and Undifferentiated disease, respectively. A significant correlation existed between diagnosis and presence of hydrops. Sensitivity and specificity were 88 per cent and 67 per cent, respectively. Intra- and inter-observer agreement for presence and grading of hydrops was near-perfect and substantial to near-perfect, respectively.

Conclusion

Magnetic resonance imaging demonstrates radiographic hydrops with significant correlation to clinical diagnosis and good intra- and inter-observer agreement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meniere DiseaseMagnetic Resonance ImagingHumansFemaleMaleMiddle AgedContrast MediaAdultAgedSensitivity and SpecificityEndolymphatic HydropsAustraliaObserver VariationAged, 80 and overGadolinium DTPA

Stichwörter der Autor:innen

inner earmagnetic resonance imagerysensorineural hearingtinnitusvertigo

Substanzen

Contrast MediaGadolinium DTPA

Autor:innen und Institutionen

  • Department of Otolaryngology and Head and Neck Surgery, Sir Charles Gairdner Hospital, Nedlands, Australia.
  • Perth Radiological Clinic, Subiaco, Australia.
  • Division of Surgery, Medical School, The University of Western Australia, Nedlands, Australia.
  • Neurological Intervention and Imaging Service of WA (NIISwa), Sir Charles Gairdner Hospital, Nedlands, Australia.
  • Department of Audiology, Fiona Stanley Hospital, Perth, Australia.
  • School of Population Health, Curtin University, Perth, Australia.

ORCID-Profile: Emily Barrett

Zitieren

APA

Barrett, E., Boeddinghaus, R., Thompson, A., Wedekind, A., Tavora-Vieira, D., & Kuthubutheen, J. (2025). Delayed contrast MRI for the evaluation of Ménière’s disease: an Australian perspective. The Journal of Laryngology & Otology. https://doi.org/10.1017/s0022215124001671

Vancouver

Barrett E, Boeddinghaus R, Thompson A, Wedekind A, Tavora-Vieira D, Kuthubutheen J. Delayed contrast MRI for the evaluation of Ménière’s disease: an Australian perspective. The Journal of Laryngology & Otology. 2025. doi:10.1017/s0022215124001671

BibTeX
@article{Barrett2025,
  author = {Barrett, Emily and Boeddinghaus, Rudolf and Thompson, Andrew and Wedekind, Andre and Tavora-Vieira, Dayse and Kuthubutheen, Jafri},
  title = {Delayed contrast MRI for the evaluation of Ménière’s disease: an Australian perspective},
  journal = {The Journal of Laryngology & Otology},
  year = {2025},
  doi = {10.1017/s0022215124001671}
}
Kostenlos starten →